Literature DB >> 35180759

Enuresis and Hyperfiltration in Children With Sickle Cell Disease.

Rima S Zahr1, Juan Ding2, Guolian Kang2, Winfred C Wang3, Jane S Hankins3, Kenneth I Ataga4, Jeffrey D Lebensburger5, Jerlym S Porter6.   

Abstract

Nocturnal enuresis is a common symptom in children with sickle cell disease (SCD). Risk factors for development of enuresis are currently unknown. An early manifestation of SCD-associated kidney damage is glomerular hyperfiltration. We test the hypothesis that in a pediatric SCD cohort, individuals with hyperfiltration are more likely to have nocturnal enuresis when compared to children without hyperfiltration. To assess the relationship between nocturnal enuresis and hyperfiltration, we retrospectively evaluated children with SCD enrolled in the Evaluation of Nocturnal Enuresis and Barriers to Treatment among Pediatric Patients with SCD study and prospectively identified children who reported nocturnal enuresis and were enrolled in the longitudinal cohort study Sickle Cell Clinical Research and Intervention Program. Nocturnal enuresis occurred in 46.5% of Pediatric Patients with Sickle Cell Disease participants and was more frequent in participants with HbSS/HbSβ 0 thalassemia and in male participants. We did not identify an association between hyperfiltration from 3 to 5 years of age with the later development of enuresis. Severe SCD genotypes and male sex were associated with nocturnal enuresis after age 5 years. We could not identify additional renal or hematologic predictors associated with the diagnosis of nocturnal enuresis. Future studies should incorporate nonrenal risk factors into studies that predict development of enuresis.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35180759      PMCID: PMC9385885          DOI: 10.1097/MPH.0000000000002426

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.170


  26 in total

1.  Hyposthenuria in sickle cell anemia: a reversible renal defect.

Authors:  H A ITANO; H G KEITEL; D THOMPSON
Journal:  J Clin Invest       Date:  1956-09       Impact factor: 14.808

2.  Sickle Cell Clinical Research and Intervention Program (SCCRIP): A lifespan cohort study for sickle cell disease progression from the pediatric stage into adulthood.

Authors:  Jane S Hankins; Jeremie H Estepp; Jason R Hodges; Martha A Villavicencio; Leslie L Robison; Mitchell J Weiss; Guolian Kang; Jane E Schreiber; Jerlym S Porter; Sue C Kaste; Kay L Saving; Paulette C Bryant; Jeffrey E Deyo; Kerri A Nottage; Allison A King; Amanda M Brandow; Jeffrey D Lebensburger; Oyebimpe Adesina; Stella T Chou; Babette S Zemel; Matthew P Smeltzer; Winfred C Wang; James G Gurney
Journal:  Pediatr Blood Cancer       Date:  2018-05-24       Impact factor: 3.167

3.  Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG).

Authors:  Winfred C Wang; Russell E Ware; Scott T Miller; Rathi V Iyer; James F Casella; Caterina P Minniti; Sohail Rana; Courtney D Thornburg; Zora R Rogers; Ram V Kalpatthi; Julio C Barredo; R Clark Brown; Sharada A Sarnaik; Thomas H Howard; Lynn W Wynn; Abdullah Kutlar; F Daniel Armstrong; Beatrice A Files; Jonathan C Goldsmith; Myron A Waclawiw; Xiangke Huang; Bruce W Thompson
Journal:  Lancet       Date:  2011-05-14       Impact factor: 79.321

4.  Effect of hydroxyurea treatment on renal function parameters: results from the multi-center placebo-controlled BABY HUG clinical trial for infants with sickle cell anemia.

Authors:  Ofelia Alvarez; Scott T Miller; Winfred C Wang; Zhaoyu Luo; M Beth McCarville; George J Schwartz; Bruce Thompson; Thomas Howard; Rathi V Iyer; Sohail R Rana; Zora R Rogers; Sharada A Sarnaik; Courtney D Thornburg; Russell E Ware
Journal:  Pediatr Blood Cancer       Date:  2012-01-31       Impact factor: 3.167

Review 5.  Renal abnormalities in sickle cell disease.

Authors:  M Allon
Journal:  Arch Intern Med       Date:  1990-03

6.  Hemolysis and acute kidney failure.

Authors:  Qi Qian; Karl A Nath; Yiming Wu; Tarek M Daoud; Sanjeev Sethi
Journal:  Am J Kidney Dis       Date:  2010-06-03       Impact factor: 8.860

7.  Haemoglobinuria is associated with chronic kidney disease and its progression in patients with sickle cell anaemia.

Authors:  Santosh L Saraf; Xu Zhang; Tamir Kanias; James P Lash; Robert E Molokie; Bharvi Oza; Catherine Lai; Julie H Rowe; Michel Gowhari; Johara Hassan; Joseph Desimone; Roberto F Machado; Mark T Gladwin; Jane A Little; Victor R Gordeuk
Journal:  Br J Haematol       Date:  2013-12-12       Impact factor: 6.998

8.  Mortality in sickle cell disease. Life expectancy and risk factors for early death.

Authors:  O S Platt; D J Brambilla; W F Rosse; P F Milner; O Castro; M H Steinberg; P P Klug
Journal:  N Engl J Med       Date:  1994-06-09       Impact factor: 91.245

9.  Sleep-disordered breathing and nocturnal hypoxemia in young adults with sickle cell disease.

Authors:  P L Whitesell; O Owoyemi; P Oneal; M Nouraie; E S Klings; A Rock; T A Mellman; T Berihun; J Lavella; R E Taylor; S P Perrine
Journal:  Sleep Med       Date:  2016-06-23       Impact factor: 3.492

10.  Hyperfiltration during early childhood precedes albuminuria in pediatric sickle cell nephropathy.

Authors:  Jeffrey D Lebensburger; Inmaculada Aban; Brandi Pernell; Malgorzata Kasztan; Daniel I Feig; Lee M Hilliard; David J Askenazi
Journal:  Am J Hematol       Date:  2019-01-08       Impact factor: 10.047

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.